Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing

Molecular Immunology

Volumn 46, Issue 8-9, 2009, Pages 1605-1612

  Rockwell, Karen R ^a,b   Huber, Brigitte T ^a  

^a TUFTS UNIVERSITY   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Bcl x; Conformation; Isoelectric focusing

Indexed keywords

BUFFER; DETERGENT; INTERLEUKIN 3; PROTEIN BCL X;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DEAMINATION; ISOELECTRIC FOCUSING; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION;

ANIMALS; BCL-X PROTEIN; CELLS, CULTURED; DEAMINATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; INTERLEUKIN-3; ISOELECTRIC FOCUSING; MICE; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN ISOFORMS; PROTEIN KINASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 64549102463     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.02.031     Document Type: Article

References (33)

1. Aritomi M., Kunishima N., Inohara N., et al. Crystal structure of rat Bcl-xL: implications for the function of the Bcl-2 protein family. J. Biol. Chem. 272 (1997) 27886-27892
2. Breckenridge D.G., Stojanovic M., Marcellus R.C., et al. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J. Cell Biol. 160 (2003) 1115-1127
3. Clem R.J., Cheng E.H., Karp C.L., et al. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 554-559
4. Conus S., Kaufmann T., Fellay I., et al. Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints. EMBO J. 19 (2000) 1534-1544
5. Deverman B.E., Cook B.L., Manson S.R., et al. Bcl-x(L) deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111 (2003) 51-62
6. Fan M., Goodwin M., Vu T., et al. Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade. J. Biol. Chem. 275 (2000) 29980-29985
7. Gonzalez-Garcia M., Perez-Ballestero R., and Ding L. Bcl-XL is the major Bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120 (1994) 3033-3042
8. Hawley R.G., Lieu F.H., and Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1 (1994) 136-138
9. Hsu Y.T., Wolter K.G., and Youle R.J. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3668-3672
10. Hsu Y.T., and Youle R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273 (1998) 10777-10783
11. Huang D.C., O'Reilly L.A., Strasser A., and Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16 (1997) 4628-4638
12. Huang D.C., and Strasser A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell 103 (2000) 839-842
13. Jia L., Macey M.G., Yin Y., et al. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood 93 (1999) 2353-2359
14. Johnstone R.W. Deamidation of Bcl-X(L): a new twist in a genotoxic murder mystery. Mol. Cell 10 (2002) 695-697
15. Karasuyama H., and Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18 (1988) 97-104
16. Kharbanda S., Saxena S., Yoshida K., et al. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J. Biol. Chem. 275 (2000) 322-327
17. Losonczi J.A., Olejniczak E.T., Betz S.F., et al. NMR studies of the anti-apoptotic protein Bcl-xL in micelles. Biochemistry 39 (2000) 11024-11033
18. Lutter P., Meyer H.E., Langer M., et al. Investigation of charge variants of rViscumin by two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 22 (2001) 2888-2897
19. Muchmore S.W., Sattler M., Liang H., et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381 (1996) 335-341
20. Muller A.J., Young J.C., Pendergast A.M., et al. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol. Cell. Biol. 11 (1991) 1785-1792
21. Mund T., Gewies A., Schoenfeld N., et al. Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum. FASEB J. 17 6 (2003) 696-698
22. Nguyen M., Breckenridge D.G., Ducret A., et al. Caspase-resistant BAP31 inhibits fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol. Cell. Biol. 20 (2000) 6731-6740
23. Nunez G., London L., Hockenbery D., et al. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144 (1990) 3602-3610
24. Poruchynsky M.S., Wang E.E., Rudin C.M., et al. Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Cancer Res. 58 (1998) 3331-3338
25. Sattler M., Ling H., Nettesheim D., et al. Structure of the Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275 (1997) 983-986
26. Shimizu S., Narita M., and Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399 (1999) 483-487
27. Shimizu S., Konishi A., Kodama T., et al. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3100-3105
28. Stegh A.H., Barnhart B.C., Volkland J., et al. Inactivation of caspase-8 on mitochondria of Bcl-xL-expressing MCF7-Fas cells: role for the bifunctional apoptosis regulator protein. J. Biol. Chem. 277 (2002) 4351-4360
29. Takehara T., and Takahashi H. Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. Cancer Res. 63 (2003) 3054-3057
30. Thuduppathy G., Craig J., Kholodenko V., et al. Evidence that membrane insertion of the cytosolic domain of BclxL is governed by an electrostatic mechanism. J. Mol. Biol. 359 4 (2006) 1045-1058
31. Tsuruta F., Masuyama N., and Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277 (2002) 14040-14047
32. Xie Z., Schendel S., Matsuyama S., et al. Acidic pH promotes dimerization of Bcl-2 family proteins. Biochemistry 37 (1998) 6410-6418
33. Zhang H., Xu Q., Krajewski S., et al. BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2597-2602